EMI Share Options: A cost-effective way to incentivise employees

Start-ups are usually posed with the same challenge: making the business a success on a limited budget. Share options can be a cost-effective way to align the interests of a company’s employees with its shareholders, in order to ensure that employees are vested in increasing the value of the company.

No items found.

The commercial imperatives of a tech start-up are rarely unique; its primary concerns are to develop a minimum viable product, establish a place in the market and gain traction with its customer base. However, in an attempt to do so, start-ups are usually posed with the same challenge: making the business a success on a limited budget.

A start-up’s seed funding, whether self-funded, raised through family and friends, a third party investor or by crowdsourcing, is only ever going to stretch so far. In view of this, it is crucial that financial resources are allocated as effectively as possible.

When a business is in its infancy, it is unlikely to have sufficient funds to pay its key employees high salaries (or even market-rate, for that matter) or award generous bonuses. Equally, there may be good reasons why existing shareholders would be reluctant to immediately give equity in the company to its employees.

A share option is the right to acquire shares in a company at a pre-determined exercise price, which usually become exercisable on the satisfaction of certain conditions. On exercise of the options, the person to whom the option was granted (the “option holder”) would be allotted shares in the company. Share options can be a cost-effective way to align the interests of a company’s employees with its shareholders, in order to ensure that employees are vested in increasing the value of the company.

Enterprise Management Incentive (“EMI”) options are a specific, tax-advantaged share option arrangement targeted at small, higher-risk trading companies. Given the risk-profile of most tech start-ups, EMI options are often the most effective way to assist with the retention and recruitment of employees.

EMI options are granted subject to detailed rules set out in an EMI option plan, which would usually include how and when the share options can be exercised, what happens on termination of employment and any other applicable terms. For an EMI option to qualify for favourable tax treatment, the option plan and grant of option must also be notified to HMRC.

Who can grant EMI options?

Broadly speaking, a company will be a “qualifying company” entitled to grant EMI options if:

  • it is independent (i.e. not a 51% subsidiary or otherwise under the control of another company);
  • any of its subsidiary companies are “qualifying subsidiaries” (i.e. 51% subsidiaries of the company);
  • the consolidated value of the group assets, without deduction of liabilities, is not more than £30,000,000;
  • it carries out one or more qualifying trading activity (note that a tech start-up would usually fulfil this requirement);
  • it has a permanent establishment in the UK; and
  • the group employs fewer than 250 people.

In addition, the total value of the shares in a company subject to unexercised EMI options must not at any time be more than £3,000,000, and the individual EMI option holder’s maximum entitlement at the date of grant of the EMI options is £250,000.

Who can EMI options be granted to?

EMI options can be granted to “eligible employees”, namely those who:

  • are employed by the company or any of its qualifying subsidiaries;
  • are committed to work at least 25 hours a week or, if less, 75% of his or her working time; and
  • do not (either individually or jointly) have direct or indirect ownership of more than 30% of the ordinary share capital of any group company.

Benefits of EMI option shares

There are many reasons why a company might want to grant EMI options, and unsurprisingly, those options can be very valuable to the recipient employees.

Perhaps most importantly from the employee’s perspective is the tax treatment of EMI options. Generally, there is no income tax liability on grant or exercise of the EMI options (unless the exercise price is less than the market value of the shares at grant).

Upon disposal of the option shares, any gain made on the shares (that is, any difference between the amount paid for the shares and their market value at the date of grant) would usually attract capital gains tax, rather than income tax, which has traditionally had a more favourable rate. Subject to certain conditions, the option holder may also be entitled to entrepreneurs’ relief at the even lower rate of 10%.

From the company’s point of view, granting EMI option shares to employees can be a cost-effective way to remunerate employees in the long-term; invaluable to a company still in its early stages operating on a shoe-string budget.

An equally important, but perhaps less obvious benefit, is the potential appeal to outside investors. Investors who are considering investing in a tech start-up are likely to scrutinise the commitment of key staff, whose know-how and expertise are central to the potential of any start-up. An EMI option plan is likely to be well-received by investors as it indicates a recognition by the company of the importance of retaining its key personnel.

Finally, companies have considerable flexibility in determining the terms of the options. EMI option terms are only subject to a handful of prescribed requirements under EMI legislation, meaning that the company is generally free to decide how the EMI options are exercised, when they lapse and what (if any) exercise conditions will apply.

For example, a company may wish for the option shares to vest with the employee over a number of years, to lock them in for a minimum period, before they can be exercised. Alternatively, the company may want to include good leaver and bad leaver provisions, setting out what happens if an employee leaves the company. In these circumstances, it may be that a “good leaver” (for example, an employee who can no longer work as they are injured) is entitled to exercise the share options for a certain period after the end of their employment.

Why granting EMI options may not be appropriate?

Invariably, granting EMI options will not be suitable for all businesses in every scenario. Whilst the option terms can be flexible, there is still extensive qualifying criteria that must be met, meaning that certain companies will not be eligible to grant EMI options.

The fact that EMI options cannot be granted in respect of shares in subsidiary companies may also prove problematic. In circumstances where there is a group structure, shareholders of the ultimate parent company may be reluctant to grant share options in that parent company, which on exercise would have the effect of diluting their control. Although it may be more desirable to grant EMI options in a subsidiary company, this is prohibited under EMI legislation.

Finally, the option holder must have the necessary funds to pay the exercise price. If the exercise price is particularly high, it may not be viable for the option holder to raise the funds to do so, which could potentially undermine the intended effect of the EMI options.

Comment

Whilst EMI options are unlikely to present a one-size-fits-all solution for tech start-ups, there are a number of unique benefits that granting EMI options can offer to both employee and company. For employees, they provide an opportunity to participate in the growth of the business in a tax-efficient way, which has the potential to be lucrative in the long-term. Conversely, EMI options are a cost-effective way for the company to ensure that employees are properly incentivised to work hard to increase the value of the business. For tech start-ups, EMI options could be a particularly useful way to hold on to key staff without depleting limited funds.

Note: the content of this article is for general information only and does not constitute legal advice. Specific legal advice should be taken in any specific circumstance.

If you have any questions on any of the points covered in this article, please do get in touch with our Corporate & Commercial Team on 01603 610911.

Article by
Alex Saunders
Partner
August 7, 2017
Article by
Leathes Prior Team
August 7, 2017
You might also like...

Selling a Probate Property: A Guide for Executors

Acting as an Executor can feel daunting, especially if there is a property which needs to be sold as part of the estate administration process. If you have been appointed as an Executor and you are unsure where to begin, here are some key things to consider.

Anna Jordan
13.05.2026

Leathes Prior welcomes new agricultural specialist to the firm

Leathes Prior is pleased to welcome Rebecca Allen to our specialist Agriculture Team.

Peter Lambert
11.05.2026

Leathes Prior's Personal Injury & Clinical Negligence Team Secure Settlement for Client

Kate Smith (Senior Associate) and Kimberley Nelson (Paralegal) were instructed in relation to a workplace personal injury claim, and successfully secured a five-figure settled for the client.

Rhiannon Bond
08.05.2026

New Restrictions to Charitable Giving: What You Need to Know

Changes to UK tax law regarding charitable giving took effect from 6 April 2026. Following legislative amendments in the Finance Act 2025-26, the generous tax exemptions associated with charitable gifts - specifically Inheritance Tax (IHT) exemptions - will be restricted to gifts to UK-registered charities. Ejike Ndaiji, Partner in our Wills, Trusts, & Probate and Charities Team explains...

Ejike Ndaji
27.04.2026

More industry insights

Stay informed with our latest legal insights.

View All

Selling a Probate Property: A Guide for Executors

Acting as an Executor can feel daunting, especially if there is a property which needs to be sold as part of the estate administration process. If you have been appointed as an Executor and you are unsure where to begin, here are some key things to consider.

Anna Jordan
13.05.2026

Leathes Prior welcomes new agricultural specialist to the firm

Leathes Prior is pleased to welcome Rebecca Allen to our specialist Agriculture Team.

Peter Lambert
11.05.2026

Leathes Prior's Personal Injury & Clinical Negligence Team Secure Settlement for Client

Kate Smith (Senior Associate) and Kimberley Nelson (Paralegal) were instructed in relation to a workplace personal injury claim, and successfully secured a five-figure settled for the client.

Rhiannon Bond
08.05.2026

New Restrictions to Charitable Giving: What You Need to Know

Changes to UK tax law regarding charitable giving took effect from 6 April 2026. Following legislative amendments in the Finance Act 2025-26, the generous tax exemptions associated with charitable gifts - specifically Inheritance Tax (IHT) exemptions - will be restricted to gifts to UK-registered charities. Ejike Ndaiji, Partner in our Wills, Trusts, & Probate and Charities Team explains...

Ejike Ndaji
27.04.2026

Charity of the Month: Crohn's & Colitis UK

Leathes Prior are delighted to be supporting Crohn’s & Colitis UK as our Charity of the Month for April 2026.

Rhiannon Bond
24.04.2026

The Fair Work Agency: ERA 2025

The Fair Work Agency (FWA) was launched on the 7 April and is a new government body that has merged three previously separate agencies into one single regulator. Dan Chapman, Partner in our Employment Team explains what this means.

Dan Chapman
21.04.2026

Employment Rights Act 2026: The New Trade Union Right Of Access - Will it matter?

The Government has now published its response to the “Make Work Pay: Trade Union Right of Access” consultation which means we are now one step closer to properly understanding what these new access rights really will be.

Dan Chapman
13.04.2026

Leathes Prior grows the firm’s People & Culture Team

Leathes Prior are delighted to announce that Jessica Bullimore has joined on a permanent basis as People & Culture Manager, further strengthening the firm’s investment in its people as it continues to grow.

Peter Lambert
08.04.2026

Leathes Prior advises Circuitlink on acquisition of Bowmonk

Leathes Prior Solicitors has advised Circuitlink PTY Limited on its acquisition of RJS UK Holdings Limited, trading as Bowmonk, a well-established UK manufacturer of vehicle testing and compliance equipment.

Peter Lambert
01.04.2026

Leathes Prior Announces Promotions for 2026

Leathes Prior announce eight key promotions across legal and operational teams

Jessica Bullimore
01.04.2026

Leathes Prior & Norfolk Community Foundation: Good for Good

Leathes Prior work in collaboration with Norfolk Community Foundation to support Voluntary, Community & Social Enterprise (VCSE) organisations through the Skills Exchange

Rhiannon Bond
23.03.2026

Charity of the Month: The Sunshine Memory Café

Leathes Prior is delighted to be supporting The Sunshine Memory Café as our Charity of the Month for March 2026, with funding being raised from our 'LP Big Fat Quiz of the 150th Year' event.

Rhiannon Bond
18.03.2026

Spring Statement 2026 - An Overview

With the Government having restricted itself to one fiscal event a year in the form of the Autumn Budget, the Spring Statement is perhaps not the dramatic moment it used to be. It is more a chance for the Government to respond to events and economic forecasts than to set policy for the future.

Sam Poulter
03.03.2026

Charity of the Month: Sue Lambert Trust

Leathes Prior is delighted to be supporting the Sue Lambert Trust as our Charity of the Month for February 2026. Sue Lambert Trust is a leading charity in Norfolk offering free therapeutic counselling and support services to survivors of sexual violence and abuse.

Rhiannon Bond
23.02.2026

Supreme Court ruling set to impact NHS - Children injured by NHS can claim damages for lifetime lost earnings

In February 2026, the Supreme Court passed a ruling which is set to significantly increase the amount of damages the NHS may have to pay for claims brought in respect of children injured at birth, as a result of medical negligence.

Kimberley Nelson
20.02.2026

The Value of Planning Ahead: LPAs & Court of Protection

Putting LPAs in place allows you to choose trusted people to make decisions for you if you lose capacity in the future. This avoids the need for loved ones to make a costly and time-consuming deputyship application to the Court of Protection. With more people likely to experience conditions affecting capacity, more families may need to turn to the Court for support where no LPAs are in place.

Jordan Walker
19.02.2026

Clinical Wills: An overview for Healthcare Practitioners

Ejike Ndaji, Partner in our Wills, Trusts and Probate Team provides an overview of Clinical Wills and their importance to Healthcare Practitioners.

Ejike Ndaji
17.02.2026

Leathes Prior assists Almalumi Group on the acquisition of Yarrowside Limited

Alex Saunders, Partner in the Leathes Prior’s Corporate Team assists Almalumi Group on the acquisition of Yarrowside Limited.

Alex Saunders
17.02.2026
Will

What do Executors and Trustees do, and who should I appoint?

Charlie Watkins, Trainee Solicitor in our Wills, Trusts & Probate Team discusses what Executors and Trustees do, and who you should appoint.

Charlie Watkins
03.02.2026

Charity of the Month: Big C

Leathes Prior is pleased to support Norfolk cancer charity, Big C as its Charity of the Month for January.

Rhiannon Bond
28.01.2026

Freddie Slater becomes the first development driver to be signed by new F1 Team Audi

Dan Chapman, Managing Partner and Head of Sports at Leathes Prior acted on behalf of Freddie Slater as he becomes the first development driver to be signed by Audi Revolut F1 Team.

Peter Lambert
26.01.2026

Business Lasting Powers of Attorney – Why Your Business Needs One

The benefits of having in place Lasting Powers of Attorney (LPA) documents for one’s personal affairs are now more widely known than was previously the case, Partner, Ejike Ndaji explains.

Ejike Ndaji
26.01.2026

Breaking Up Doesn’t Have to Be Hard: FAQs for Break Clauses in Commercial Leases

Georgia Sartin, Solicitor in our Property Disputes Team answers some frequently asked questions around break clauses in commercial property leases.

Georgia Sartin
23.01.2026

The case of the fake cases: another judgment on AI-hallucinations in litigation

The use of AI Large Language Models in litigation continues to generate headlines (and consternation from the judiciary). In 2025, it seemed that rarely a month went by without a new case on fake AI-generated case law. December was no exception, and the High Court has now issued a further warning regarding the use of AI by litigants.

Chris Goodwin
15.01.2026

LP Celebrates 150th Anniversary

To begin a year of celebrations, this week Leathes Prior are delighted to reveal our refreshed brand identity and website.

Peter Lambert
05.01.2026

Get in Touch

By clicking submit, you agree to our Privacy Policy

Submit
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.